Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1
- PMID: 34973107
- PMCID: PMC8816532
- DOI: 10.1007/s10147-021-02081-w
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1
Abstract
In 2017, the Japan Society of Clinical Oncology (JSCO) published the JSCO Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients. These were the first Japanese guidelines to address issues of oncofertility. In this field of medicine, sustained close cooperation between oncologists and reproductive specialists is essential from the diagnosis of cancer until many years after completion of cancer treatment. These JSCO guidelines were intended to guide multidisciplinary medical staff in considering the availability of fertility preservation options and to help them decide whether to provide fertility preservation to childhood, adolescent, and young adult cancer patients before treatment starts, with the ultimate goal of improving patient survivorship. The guidelines are presented as Parts 1 and 2. This article (Part 1) summarizes the goals of the guidelines and the methods used to develop them and provides an overview of fertility preservation across all oncology areas. It includes general remarks on the basic concepts surrounding fertility preservation and explanations of the impacts of cancer treatment on gonadal function by sex and treatment modality and of the options for protecting/preserving gonadal function and makes recommendations based on 4 clinical questions. Part 2 of these guidelines provides specific recommendations on fertility preservation in 8 types of cancer (gynecologic, breast, urologic, pediatric, hematologic, bone and soft tissue, brain, and digestive).
Keywords: Childhood, adolescent and young adult (CAYA); Fertility preservation; Practice guideline.
© 2021. The Author(s).
Conflict of interest statement
All members of the Guideline Working Committee behaved in accordance with the JSCO Guidelines for Conflicts of Interest Issues Related to Clinical Studies of Oncology. Potential conflicts of interest of individual committee members are declared at http://www.jscocpg.jp/item/32/coi.html. Development of these JSCO Guidelines was entirely funded by the JSCO. Neither the opinions nor the interests of the funding body (JSCO) affected the final guideline recommendations.
References
-
- ASCO Recommendations on Fertility Preservation in Cancer Patients J Clin Oncol. 2006;24:2917–2931. - PubMed
-
- von Wolff M, Montag M, Dittrich R, et al. Fertility preservation in women–a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet. 2011;284:427–435. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical